Ernexa Therapeutics Inc. Operating Lease, Payments
Ernexa Therapeutics Inc. (ERNA) reported Operating Lease, Payments of $25.00 thousand for the 12-month period ending 2021-12-31, per its 10-K/A filed 2022-07-01.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2022-07-01
- Ernexa Therapeutics Inc. operating lease, payments for the quarter ending 2021-12-31 was -$331.00.
- Ernexa Therapeutics Inc. operating lease, payments for the quarter ending 2021-09-30 was $0.00.
- Ernexa Therapeutics Inc. operating lease, payments for the quarter ending 2021-06-30 was -$129.31K.
- Ernexa Therapeutics Inc. operating lease, payments for the quarter ending 2021-03-31 was $154.64K.
- Ernexa Therapeutics Inc. operating lease, payments for fiscal 2021 was $25.00K.
- Ernexa Therapeutics Inc. operating lease, payments for fiscal 2019 was $215.00K.
| Period end | Operating Lease, Payments 0 month | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | -$331.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-01 | -$331.00 derived: sum of 2 quarters · filed 2022-07-01 | -$129.64K derived: sum of 3 quarters · filed 2022-07-01 | $25.00K 10-K/A · filed 2022-07-01 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$129.31K derived: sum of 2 quarters · filed 2021-11-12 | $25.33K 10-Q · filed 2021-11-12 | ||
| 2021-06-30 | -$129.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $25.33K 10-Q · filed 2021-08-13 | |||
| 2021-03-31 | $154.64K 10-Q · filed 2021-05-17 | ||||
| 2019-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $187.00K derived: sum of 2 quarters · filed 2020-03-19 | $187.00K derived: sum of 3 quarters · filed 2020-03-19 | $215.00K 10-K · filed 2020-03-19 | |
| 2019-09-30 | $83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $83.00K derived: sum of 2 quarters · filed 2019-11-01 | $111.00K 10-Q · filed 2019-11-01 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $28.00K 10-Q · filed 2019-08-12 | |||
| 2019-03-31 | $28.00K 10-Q · filed 2019-05-14 | ||||
| 2019-01-02 | $58.00K 10-Q · filed 2019-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |